FDA
approval
· 2021-08-18
FDA Approved: JUNEL 21 DAY — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
Summary
FDA approved a supplemental application for Junel 21 Day (norethindrone acetate and ethinyl estradiol) from Teva Pharmaceuticals USA, Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for JUNEL 21 DAY (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL)